Xcout Intel
Abcuro, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Abcuro, Inc. among biotechnology companies — ranked by similarity to what Abcuro, Inc. actually does, not by market-cap band.
Subscribe to see Abcuro, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Abcuro, Inc.
Abcuro, Inc. is a biotechnology company headquartered in Newton, Massachusetts, focused on developing advanced immunotherapies to treat autoimmune diseases and cancer.
Abcuro, Inc. at a glance
Abcuro, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $39.4M in August 2026. Xcout tracks 28 named people at Abcuro, Inc., including Alex Martin (Chief Executive Officer).
Abcuro, Inc. leadership
- Alex MartinChief Executive Officer
- John Alexander MartinChief Executive Officer
- Karen TubridyChief Operating Officer
- Jeffrey WilkinsChief Medical Officer
- Steven A. GreenbergChief Scientific Advisor & Co-Founder
- Dave BorbasResearch VP, Head of Data Management
22 more named people on record for Abcuro, Inc., with roles, board committees and tenure — see the full roster →
Abcuro, Inc. funding rounds
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $39.4M | — | |
| Series C | $200M | 13 named | |
| SEC Form D filing | $120.1M | — | |
| — | $42M | 13 named | |
| SEC Form D filing | $15.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Abcuro, Inc. competitors
Ranked by semantic similarity — how close each company is to Abcuro, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Auron Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts. The company focuses on targeting cell states to deliver next-generation targeted cancer therapies.
Life Sciences
Accropeutics (Accro Bioscience) is a biotechnology research company headquartered in Suzhou, Jiangsu, China. The company discovers and develops innovative drugs targeting inflammation, autoimmune diseases, and cancer.
Biotech
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Similar biotechnology company
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
Similar biotechnology company
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
Similar biotechnology company
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, with an additional office in Belgium. The company focuses on discovering and developing novel immuno-oncology therapeutics for cancer treatment.
Similar biotechnology company
Ankyra Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The company develops localized immune-mediated therapies for the treatment of cancer.
Similar biotechnology company
Kanyos Bio, Inc. is a biotechnology company located in Cambridge, Massachusetts, created as a subsidiary of Anokion SA to develop clinical candidates for immune tolerance.
Similar biotechnology company
Oblenio Bio is a biotechnology research company headquartered in Lexington, Massachusetts, focused on transforming the treatment of refractory autoimmune diseases by delivering a broad immune system reset.
Similar biotechnology company
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Biotech
Abpro Holdings, Inc. is a biotechnology firm specializing in the creation of innovative antibody treatments, primarily targeting immuno-oncology and ophthalmology. The company leverages two proprietary technological platforms: DiversImmune, a discovery platform that identifies a broad spectrum of unique antibodies against both established and emerging therapeutic targets, and MultiMab, an engineering platform offering the versatility to assemble antibody components into customized, multi-specific constructs tailored for specific therapeutic needs. Abpro's flagship therapeutic pipeline includes ABP-102, a next-generation immuno-oncology TetraBi antibody engineered to dually target HER2 and CD3, offering a potential treatment for HER2-positive solid tumors like breast and gastric cancers. Another key candidate, ABP-201, is a TetraBi antibody designed to simultaneously inhibit both VEGF and ANG-2 pathways for the management of vascular eye diseases, such as diabetic macular edema and wet age-related macular degeneration. The company's pipeline also features ABP-110, a TetraBi antibody targeting GPC3 and CD3 for hepatocellular carcinoma, and ABP-150, another TetraBi antibody focused on claudin 18.2 and CD3 for gastric cancers. Abpro maintains strategic alliances with Celltrion Inc. and Abpro Bio International, Inc. Established in 2004, Abpro Holdings, Inc. is headquartered in Woburn, Massachusetts.
Similar biotechnology company
GlycoEra AG is a biotechnology company focused on advancing glycan-mediated therapy through game-changing protein engineering. Headquartered in Wädenswil, Switzerland, the company also maintains an office in Newton, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Abcuro, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Abcuro, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →